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Background: We investigated the prevalence of plasmid-mediated quinolone resistance and its association with extended-spec-
trum beta-lactamase (ESBL) and AmpC beta-lactamase in Enterobacteriaceae.
Methods: A total of 347 non-duplicated isolates of Enterobacteriaceae were collected between August and October 2006 from 2 hos-
pitals. Qnr determinant screening was conducted using PCR amplification, and all positive results were confirmed by direct sequenc-
ing. Qnr-positive strains were determined on the basis of the presence of ESBL and AmpC beta-lactamase genes.
Results: The qnr gene was detected in 47 of 347 clinical Enterobacteriaceae isolates. Among the 47 qnr-positive strains, Klebsiella 
pneumoniae (N=29) was the most common, followed by Escherichia coli (N=6), Enterobacter cloacae (N=6), Citrobacter freundii 
(N=5), and Enterobacter aerogenes (N=1). These isolates were identified as qnrA1 (N=6), 8 qnrB subtypes (N=40), and qnrS1 (N= 
1). At least 1 ESBL was detected in 38 of the 47 qnr-positive strains. Qnr-positive strains also showed high positive rates of ESBL or 
AmpC beta-lactamase, such as TEM, SHV, CTX-M, and DHA. DHA-1 was detected in 23 of 47 qnr-positive strains, and this was co-
produced with 1 qnrA1 and 22 qnrB4. Strains harboring MIR-1T and CMY were also detected among the qnr-positive strains. Anti-
microbial-resistance rates of qnr-positive strains to ciprofloxacin, levofloxacin, norfloxacin, nalidixic acid, and moxifloxacin were 
51.1%, 46.8%, 46.8%, 74.5%, and 53.2%, respectively. 
Conclusions: The qnr genes were highly prevalent in Enterobacteriaceae, primarily the qnrB subtypes. They were closely associated 
with EBSL and AmpC beta-lactamase. 
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INTRODUCTION
The first plasmid-mediated quinolone resistance determi-
nant, qnrA, was reported in 1998 in a Klebsiella pneumoniae 
strain from the United States [1]. Since then, 2 additional 
qnr determinants, qnrB and qnrS, have been identified in 
Enterobacteriaceae species [2, 3]. These determinants in-
crease the minimum inhibitory concentrations (MICs) of 
quinolones by 8- to 32-fold, preventing the inhibition of 
DNA gyrase [4]. These 3 major groups of qnr determinants 
have since been detected in various Enterobacteriaceae spe-
cies worldwide [5-9], and many qnr variants are listed in 
GenBank. Among them, qnrB sequences are particularly 
numerous; hence, qnrB sequences with the same allele num-
ber and dissimilar sequences submitted by different investi-
gators or with the same sequences and different allele num-
bers can be found [10]. This situation results in confusion 
for many investigators when numbering their qnr sequences, 
particularly qnrB variants; thus, Jacoby et al. [10] adjusted 258     www.kjlm.org
Jeong HS, et al.  •  Qnr and Its Association with ESBL and AmpC
http://dx.doi.org/10.3343/kjlm.2011.31.4.257
KJLM
all previously submitted sequences and proposed a new, well-
organized numbering system for qnr alleles. 
Association of qnr genes with extended-spectrum beta-
lactamases (ESBLs) or AmpC beta-lactamases is also note-
worthy; some strains containing a qnrA gene express class 
A or class C beta-lactamase, such as SHV, CTX, VEB-1, or 
DHA-1 [11, 12]. Some reports show an association of qnrB 
with an ESBL and AmpC beta-lactamase [3, 13]. 
Although there are some reports examining the preva-
lence of qnr determinants in Korea, these were restricted to 
specific bacterial species such as Escherichia coli, K. pneu­
moniae, Enterobacter cloacae, Citrobacter freundii, and Ser­
ratia marcescens regardless of the type of specimen [8, 13-
16]. Additionally, there are few data regarding the differences 
in qnr prevalence according to the type of clinical specimen 
and bacterial species and its association with various ESBLs 
and AmpC beta-lactamases. The aims of this study were to 
investigate the prevalence of 3 groups of plasmid-mediated 
quinolone resistance determinants (qnrA, qnrB, and qnrS) 
and to examine the association of these determinants with 
ESBLs and AmpC beta-lactamases in Enterobacteriaceae.
MATERIALS AND METHODS
1. Strains
A total of 347 non-duplicated clinical strains of Entero­
bacteriaceae were collected from various clinical specimens 
from 2 hospitals, namely, the 902-bed tertiary-care Busan 
Paik Hospital (N=267) and the 200-bed secondary-care 
Dongrae Paik Hospital (N=80) in 2006. Sampling locations 
included urine (N=150), sputum or bronchial washings 
(N=59), abscess or wound pus (N=52), drainage discharge 
(N=30), peritoneal fluid (N=14), cervical discharge (N= 
10), gastric juice (N=6), blood culture (N=6), tissue (N= 
4), stool (N=4), bile (N=3), vaginal discharge (N=3), pleu-
ral fluid (N=2), catheter tip (N=2), intrauterine device (N= 
1), and cerebrospinal fluid (N=1). The strains were identi-
fied using routine laboratory protocols, including conven-
tional biochemical tests and the VITEK system (bioMèrieux 
Vitek Inc., Hazelwood, MO, USA). These strains were iden-
tified as E. coli (N=159), K. pneumoniae (N=100), E. cloa­
cae (N=30), S. marcescens (N=13), Proteus mirabilis (N=10), 
Morganella morganii (N=6), C. freundii (N=7), Enterobac­
ter aerogenes (N=4), Klebsiella oxytoca (N=3), Citrobacter 
braakii (N=2), Proteus vulgaris (N=2), Proteus penneri (N= 
2), Citrobacter amalonaticus (N=1), Enterobacter asburiae 
(N=1), Enterobacter hormaechei (N=1), Enterobacter inter­
medius (N=1), Escherichia fergusonii (N=1), Klebsiella rhi­
noscleromatis (N=1), Klebsiella species (N=1), Providencia 
rettgeri (N=1), and Providencia stuartii (N=1). All isolates 
were stored in skim milk at -70˚C until further molecular 
and microbiological evaluation.
2. PCR and sequencing for qnr genes
Genomic DNA of the bacterial strains was amplified by 
PCR for the detection of 3 groups of qnr determinants (qnrA, 
qnrB, and qnrS) as described by Gay et al. [5]. All procedures 
for PCR and sequencing were the same as those described 
in our previous report [8]. Briefly, colonies were suspended 
in 50 µL of water in a microcentrifuge tube and boiled to 
prepare DNA templates. The primers used to amplify qnrA 
to yield a 516-bp product were 5´-ATTTCTCACGCCAG-
GATTTG-3´ and 5´-GATCGGCAAAGGTTAGGTCA-3´. 
Those used for qnrB to yield a 469-bp product were 5´-GA-
TCGTGAAAGCCAGAAAGG-3´ and 5´-ACGATGCCTG-
GTAGTTGTCC-3´. Those used for qnrS to yield a 417-bp 
product were 5´-ACGACATTCGTCAACTGCAA-3´ and 
5´-TAAATTGGCACCCTGTAGGC-3´. The 3 primer pairs 
were added to a template and PCR premix (Bioneer, Dae-
jeon, Korea). PCR conditions were 94˚C for 45 sec, 53˚C for 
45 sec, and 72˚C for 60 sec, with the cycle repeated 32 times. 
Reaction mixtures without a DNA template served as nega-
tive controls. All positive amplicons were sequenced to con-
firm the subtypes of the 3 qnr genes. Amplified DNA was 
isolated using the Qiagen gel extraction kit (Qiagen Inc., 
Hilden, Germany), and sequencing was performed using 
the Big Dye Terminator Cycle Sequencing kit (Applied Bio-
systems, Foster City, CA, USA) and an ABI PRISM 3130xl 
genetic analyzer (Applied Biosystems). Both amplicon strands 
were sequenced using the same primers as for PCR amplifi-
cation. We numbered the qnr allele subtypes according to 
the qnr gene nomenclature of Jacoby et al. [10].
3.   PCR and sequencing for ambler class A beta-lactamase 
and plasmid-mediated AmpC beta-lactamase among 
qnr-positive strains. 
Plasmid DNA was extracted using a Qiagen Plasmid Pu-
rification kit (Qiagen Inc.) following the manufacturer’s re-
commendations to detect ESBL and AmpC beta-lactamase 
in qnr-positive strains. In previous experiments, this plas-
mid DNA was used as a template for PCR with a series of 
primers designed to detect class A beta-lactamase genes and 
their extended-spectrum derivatives (Table 1): blaCTX-M-1, 
blaCTX-M-2, blaCTX-M-8, blaCTX-M-9, blaPER-1, blaVEB, blaIBC/GES, bla­
TEM, and blaSHV [17, 18]. PCR products were subjected to di-
rect sequencing, with both strands being sequenced to re-
duce error. We also investigated the presence of plasmid-me-
diated AmpC beta-lactamase among qnr-positive strains Jeong HS, et al.  •  Qnr and its association with ESBL and AmpC
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Table 1. Primers used for the detection and sequencing of class A beta-lactamases and plasmid-mediated AmpC beta-lactamases
PCR target Primer name               Primer sequence Used for Reference
blaCTX-M (CTX-M-1 cluster) CTX-M-1F 5´-CCG TCA CGC TGT TGT TAG G-3´ [17]
CTX-M-1R 5´-GAC GAT TTT AGC CGC CGA C-3´
BM-1F 5´-ACT ATG GCA CCA CCA ACG AT-3´ [17]
FM-1R 5´-TTC GGT TCG CTT TCA CTT TT-3´
blaCTX-M (CTX-M-2 cluster) CTX-M-2F 5´-CGG TGC TTA AAC AGA GCG AG-3´ [17]
CTX-M-2R 5´-CCA TGA ATA AGC AGC TGA TTG CCC-3´
blaCTX-M (CTX-M-8 cluster) CTX-M-8F 5´-ACG CTC AAC ACC GCG ATC-3´ [17]
CTX-M-8R 5´-CGT GGG TTC TCG GGG ATA A-3´
blaCTX-M (CTX-M-9 cluster) CTX-M-9F 5´-GAT TGA CCG TAT TGG GAG TTT-3´ [17]
CTX-M-9R 5´-CGG CTG GGT AAA ATA GGT CA-3´
blaPER-1 PER-1F 5´-GTT AAT TTG GGC TTA GGG CAG-3´ [17]
PER-1R 5´-CAG CGC AAT CCC CAC TGT-3´
blaVEB VEB-F 5´-ACC AGA TAG GAG TAC AGA CAT ATG A-3´ [17]
VEB-R 5´ -TTC ATC ACC GCG ATA AAG CAC-3´
blaGES and blaIBC GES/IBC-F 5´-GTT AGA CGG GCG TAC AAA GAT AAT-3´ [17]
GES/IBC-R 5´-TGT CCG TGC TCA GGA TGA GT-3´
blaTEM TEM-F 5´-ATG AGT ATT CAA CAT TTC CGT-3´ [18]
TEM-R 5´-TTA CCA ATG CTT AAT CAG TGA-3´
blaSHV SHV-F 5´-CCG GGT TAT TCT TAT TTG TCG CT-3´ [18]
SHV-R 5´-TAG CGT TGC CAG TGC TCG-3´
blaMOX-1, blaMOX-2, blaCMY-1,  blaCMY-8 to blaCMY-11 MOXMF 5´-GCT GCT CAA GGA GCA CAG GAT-3´ [19]
MOXMR 5´-CAC ATT GAC ATA GGT GTG GTG C-3´
blaLAT-1 to blaLAT-4,  blaCMY-2 to blaCMY-7, blaBIL-1 CITMF 5´-TGG CCA GAA CTG ACA GGC AAA-3´ [19]
CITMR 5´-TTT CTC CTG AAC GTG GCT GGC-3´
blaDHA-1, blaDHA-2 DHAMF 5´-AAC TTT CAC AGG TGT GCT GGG T-3´ [19]
DHAMR 5´-CCG TAC GCA TAC TGG CTT TGC-3´
blaACC ACCMF 5´-AAC AGC CTC AGC AGC CGG TTA-3´ [19]
ACCMR 5´-TTC GCC GCA ATC ATC CCT AGC-3´
blaMIR-1T, blaACT-1 EBCMR 5´-TCG GTA AAG CCG ATG TTG CGG-3´ [19]
EBCMR 5´-CTT CCA CTG CGG CTG CCA GTT-3´
blaFOX-1 to blaFOX-5b FOXMF 5´-AAC ATG GGG TAT CAG GGA GAT G-3´ [19]
FOXMR 5´-CAA AGC GCG TAA CCG GAT TGG-3´
blaDHA-1 DHA-1-LF 5´-GGG GAG ATA ACG TCT GAC CA-3´ Sequencing [27]
DHA-1-LR 5´-TAG CCA GAT CCA GCA ATG TG-3´
DHA-1-MF 5´-AAC TTT CAC AGG TGT GCT GGG T-3´
DHA-1-MR 5´-CCG TAC GCA TAC TGG CTT TGC-3´
DHA-1-RF 5´-GCT GGG GTT ATC TCA CAC CT-3´
DHA-1-RR 5´-AAA TTA CGG CCC CGG CGT GT-3´
blaACT-1 PCACT-1F 5´-CTT GAA CTG CTA TTA CGG-3´ Sequencing [28]
PCACT-1R 5´-GCA ATG TTT ACT ACA GCG-3´
blaMIR-1 PCACT-1F 5´-CTT GAA CTG CTA TTA CGG-3´ Sequencing [28] 
MIR-1R 5´-GCA ATG TTT TAC TGC AGC G-3´
blaCMY-2 CMY-2XF 5´-AAC ACA CTG ATT GCG TCT GA-3´ Sequencing [19, 29]
CMY-2XR 5´-CTG GGC CTC ATC GTC AGT TA-3´260     www.kjlm.org
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using the primers developed by Perez-Perez and Hanson for 
6 groups: ACC, FOX, MOX/CMY, DHA, CIT, and EBC [19]. 
These groups could be used to detect the following target 
genes: blaDHA, blaMOX, blaCMY, blaLAT, blaBIL, blaACC, blaMIR, blaACT, 
and blaFOX. We used 2 multiplex PCR methods described by 
Lee et al. [20] that were modified from the method of Perez-
Perez and Hanson [19] to amplify the plasmid-mediated 
AmpC beta-lactamase genes. We used additional primers 
for sequencing the plasmid-mediated AmpC beta-lactamase 
genes and identified them by sequencing the PCR-amplified 
products. Primers used for the detection and sequencing of 
ESBL and the plasmid-mediated AmpC beta-lactamase are 
shown in Table 1.
4. Antimicrobial susceptibility tests
Susceptibility testing against quinolones was determined 
using the broth microdilution method recommended by the 
CLSI [21]. Isolates were tested against the following 5 agents 
in cation-adjusted Mueller-Hinton broth (BD, Sparks, MD, 
USA): ciprofloxacin (Sigma, Steinheim, Germany), levoflox-
acin (Sigma), norfloxacin (Sigma), nalidixic acid (Sigma), 
and moxifloxacin (Bayer AG, Wuppertal, Germany). MICs 
were determined after incubation at 35˚C for 24 hr in ambi-
ent air. E. coli ATCC 25922 was used as the control strain. 
The interpretive criteria were those published in the relevant 
CLSI document [22]. For other antimicrobial agents, sus-
ceptibility testing was in accordance with routine laboratory 
protocols performed using the VITEK system or the disk 
diffusion assay.
RESULTS 
1. Prevalence of qnr genes and their subtypes
The qnr gene was detected in 47 of the 347 Enterobacteri­
aceae isolates by using PCR and sequencing. The positive 
rates were higher among organisms from the tertiary-care 
hospital (15.7%, N=42) than in the secondary-care facility 
(6.3%, N=5). The specimens showing qnr-positive results 
included sputum (N=15), urine (N=13), wound pus (N= 
10), drainage discharge (N=4), peritoneal fluid (N=2), cer-
vical discharge (N=1), pleural fluid (N=1), and stool (N= 
1). Qnr genes were detected at a higher rate in respiratory 
specimens (15/59, 25.4%) than in urine (13/150, 8.7%). The 
most commonly observed qnr-positive pathogen was K. pne­
umoniae (N=29), followed by E. coli (N=6), E. cloacae (N= 
6), C. freundii (N=5), and E. aerogenes (N=1).
Ten qnr subtypes, including 1 qnrA, 8 qnrB, and 1 qnrS, 
were detected. There was a considerable difference in sub-
types according to the specific species (Table 2). Thus, qnrA 
was primarily detected in E. cloacae and E. coli; on the other 
hand, qnrB was highly prevalent in K. pneumoniae. The qnrA 
gene was detected in 6 of the 47 qnr-positive isolates, and 
the sequence was identical for all strains. The qnrB gene was 
detected in 40 of the 47 qnr-positive isolates. These isolates 
showed considerable multiplicity of subtypes and sequences. 
The high rates of the qnrB4 subtype among qnrB subtypes 
(29/40) should be noted. In addition to these qnrB4 subtypes, 
1 isolate containing qnrB1, 3 having qnrB2, 1 having qnrB6, 
1 having qnrB7, 2 having qnrB8, 2 having qnrB9, and 1 hav-
ing qnrB12 were detected. The qnrS1 gene was found in only 
1 strain and exhibited 100% identity with the reference qnrS1 
gene sequence.
2.   Association of qnr-positive strains with ambler class A 
beta-lactamase and plasmid-mediated AmpC  
beta-lactamase
At least 1 ESBL or AmpC beta-lactamase was detected in 
38 of the 47 qnr-positive isolates (Table 3). The beta-lacta-
mase production rates of qnr-positive K. pneumoniae, E. coli, 
E. cloacae, and C. freundii were 82.8% (24/29), 66.7% (4/6), 
100% (6/6), and 80.0% (4/5), respectively. No ESBLs were 
detected in E. aerogenes harboring qnrB8. The qnr-positive 
strains showed high positive rates of beta-lactamases such as 
TEM, SHV, CTX-M, and DHA. CTX-M-3, CTX-M-9, and 
SHV-12 were highly prevalent among ambler class A beta-
lactamases. In plasmid-mediated AmpC beta-lacta  mase, 
DHA-1 was detected in 23 of 47 qnr-positive strains and was 
co-produced with 1 qnrA1 and 22 qnrB4. Strains harboring 
MIR-1T and CMY primers were also detected among qnr-
positive isolates. There were no qnr-positive clinical isolates 
harboring MOX, ACC, FOX, PER-1, VEB, or GES.
Table 2. Prevalence of qnr subtypes and variants according to species 
qnr subtype C. freundii E. aerogenes E. cloacae E. coli K. pneumoniae Total
qnrA1 4 2 6
qnrB1 1 1
qnrB2 1 1 1 3
qnrB4 1 3 25 29
qnrB6 1 1
qnrB7 1 1
qnrB8 1 1 2
qnrB9 2 2
qnrB12 1 1
qnrS1 1 1
Total 5 1 6 6 29 47
Abbreviations: qnr, quinolone resistance gene; C. freundii, Citrobacter freundii; E. aero-
genes, Enterobacter aerogenes; E. cloacae, Enterobacter cloacae; E. coli, Escherichia coli; 
K. pneumoniae, Klebsiella pneumoniae.Jeong HS, et al.  •  Qnr and its association with ESBL and AmpC
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3. Antimicrobial Susceptibility to Quinolone Agents 
Of the 47 qnr-positive strains examined, the resistance 
rates to ampicillin, ampicillin-sulbactam, aztreonam, cefa-
zolin, tobramycin, amikacin, ceftriaxone, cefepime, and tri-
methoprim-sulfamethoxazole were 100%, 84.8%, 69.6%, 
87.0%, 69.6%, 43.5%, 45.7%, 34.8%, and 47.8%, respectively. 
The antimicrobial-resistance rates of qnr-positive strains to 
ciprofloxacin, levofloxacin, norfloxacin, nalidixic acid, and 
moxifloxacin were 51.1%, 46.8%, 46.8%, 74.5%, and 53.2%, 
respectively (Table 4). The plasmid-mediated quinolone re-
sistance rate was very high in both quinolone-resistant (24/ 
96) and quinolone-susceptible strains (22/248). No imipe-
nem- or meropenem-resistant strains of Enterobacteriaceae 
were observed. 
DISCUSSION
In this study, 47 of 347 (12.4%) Enterobacteriaceae showed 
qnr positive results. There was a considerable difference in 
qnr prevalence between the tertiary-care (15.7%) and sec-
ondary-care hospitals (6.3%) evaluated in this study. Gener-
ally, antimicrobial resistance rates are higher in tertiary-care 
hospitals [23, 24], and these differences are thought to be 
applicable to qnr-positive rates. Although several articles re-
garding qnr genes have been published, they focus on a spe-
cific species and do not report specimen types. In the pres-
ent study, we isolated qnr-positive strains from various clin-
ical specimens. We also observed a characteristically high 
qnr-positive rate of respiratory specimens (25.4%) compar  ed 
with other specimens, including urine (8.7%), wound pus 
(19.2%), discharge (13.3%), and peritoneal fluid (14.3%). This 
Table 3. Qnr subtype and association with class A beta-lactamase and plasmid-mediated AmpC beta-lactamase
Qnr variant Species N CTX-M SHV TEM DHA-1 MIR-1T CMY
qnrA1 E. coli 1
E. coli 1 CTX-M-3+9
E. cloacae 2 CTX-M-9
E. cloacae 1 CTX-M-9 SHV-12
E. cloacae 1 SHV-12 DHA-1
qnrB1 K. pneumoniae 1
qnrB2 E. coli 1
K. pneumoniae 1 SHV-12
E. cloacae 1 SHV-12 ACT-1
qnrB4 K. pneumoniae 2
E. coli 1 CTX-M-15 DHA-1
K. pneumoniae 3 CTX-M-3 SHV-12 DHA-1
K. pneumoniae 1 CTX-M-3 SHV-12
K. pneumoniae (3)/E. cloacae (1) 4 CTX-M-3 DHA-1
K. pneumoniae 1 CTX-M-9
K. pneumoniae (2)/E. coli (1) 3 DHA-1
K. pneumoniae 2 SHV-12
K. pneumoniae 9 SHV-12 DHA-1
K. pneumoniae 2 SHV-2a DHA-1
E. coli 1 TEM-31
qnrB6 K. pneumoniae 1
qnrB7 C. freundii 1 CMY-34-like (P201Q)
qnrB8 E. aerogenes 1
C. freundii 1 CTX-M-3
qnrB9 C. freundii 2 CMY-2
qnrB12 C. freundii 1
qnrS1 K. pneumoniae 1
Abbreviations: qnr, quinolone resistance gene; E. coli, Escherichia coli; E. cloacae, Enterobacter cloacae; K. pneumoniae, Klebsiella pneumoniae; C. freundii, Citrobacter freundii; E. aero-
genes, Enterobacter aerogenes. 262     www.kjlm.org
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Table 4. MICs of 47 qnr-positive isolates to quinolones
Species and qnr gene N
MIC range (MIC50/MIC90) (μg/mL)
CIP LEV NOR NAL MOX
K. pneumoniae (N=29)
 qnrB1  1 <0.03 0.06 0.12 2 0.06
 qnrB2  1 2 2 8 256 2
 qnrB4  25 0.12->256 (128/256) 0.12-256 (32/128) 1->256 (256/>256) 16->256 (>256/>256) 0.06->256 (8/256)
 qnrB6  1 >256 64 >256 >256 256
 qnrS1  1 256 128 >256 >256 >256
E. coli (N=6)
 qnrA1  2 16-128 8-64 32->256 >256->256 16-128
 qnrB2  1 0.25 0.5 1 >256 2
 qnrB4  3 0.12->256 0.03-64 0.25->256 2->256 0.06-256
E. cloacae (N=6)
 qnrA1  4 0.05-1 0.5-1 0.5-2 16-32 2-4
 qnrB2  1 4 2 4 >256 4
 qnrB4  1 256 64 >256 >256 128
C. freundii (N=5)
 qnrB7  1 <0.03 0.12 0.12 8 1
 qnrB8  1 <0.03 0.06 0.5 4 0.25
 qnrB9  2 <0.03-<0.03 0.12-0.12 0.25-1 8-32 1-1
 qnrB12  1 0.25 0.25 1 8 1
E. aerogenes (N=1)
 qnrB8  1 0.25 0.06 1 4 0.25
Abbreviations: qnr, quinolone resistance gene; MIC, minimum inhibitory concentration; K. pneumoniae, Klebsiella pneumoniae; E. coli, Escherichia coli; E. cloacae, Enterobacter cloa-
cae; C. freundii, Citrobacter freundii; E. aerogenes, Enterobacter aerogenes.
may be because K. pneumoniae is highly prevalent in respi-
ratory specimens. Because qnr-positive strains can spread 
in hospital environments and cause fatal nosocomial infec-
tion, the prevalence of qnr genes should be periodically in-
vestigated. 
The numbers of qnrB subtypes were diverse compared 
with those found in our previous study [8]. Additionally, 6 
qnrA strains were different from those in our previous study. 
We confirmed that qnrA1 (6/47) and qnrB4 (29/47) strains 
were common, with these 2 subtypes accounting for 74.5% 
(35/47) of the total qnr-positive strains. 
The prevalence of the qnr gene was caused by qnrB4-pos-
itive K. pneumoniae in our hospital; a significant number of 
the qnr-positive strains were of this unique subtype. Althou  gh 
the rate of qnr in C. freundii (42.9%) was relatively high, the 
numbers of C. freundii were small. Few reports have inves-
tigated qnr prevalence in C. freundii; hence, further evalua-
tion is necessary [16, 25].
The presence of qnr was significantly related to the co-
pro  duction of ESBL or AmpC beta-lactamase. Surprisingly, 
at least 1 ESBL was detected in 38 of 47 qnr-positive isolates 
examined in this study. The 14, 21, and 3 qnr-positive strains 
showed co-production of ESBL or AmpC beta-lactamase in 
1, 2, and 3 genes, respectively. This is primarily attributable 
to the qnrA1 and qnrB4 subtypes.
There are some reports of an association between qnr and 
ESBL. Wang et al. [11] reported that several qnrA-positive 
strains produced SHV-7 and CTX-M-9. In our study, CTX-
M-9 was common (4 of 6) among qnrA1-positive strains, 
but 1 strain produced SHV-12 instead of SHV-7. Another 
report revealed positive results for both qnrA and VEB-1 in 
E. coli [6]. The investigators subsequently detected the qnrA 
gene in 11 of 23 blaVEB-1-positive Enterobacter sakazakii stra-
ins from Bangkok [26]. They also stated that the qnrA gene 
was not identified in positive enterobacterial isolates from 
any country except in previous 2 reports. No VEB-1-posi-
tive strain was identified among the 47 qnr-positive Entero­
bacteriaceae examined in our study.
In Korea, Pai et al. [13] described a clear association be-
tween qnrB4 and DHA-1 strains. In our study, many qnrB4-
positive strains contained DHA-1 and, except for qnrB4 stra-
ins, only 1 strain produced DHA-1 in qnrA1 among all qnr Jeong HS, et al.  •  Qnr and its association with ESBL and AmpC
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subtypes. Thus, we presumed that an association exists be-
tween qnrB4 and DHA-1. However, this association does 
not appear to be limited to DHA-1. Although Pai et al. [13] 
stated that qnrB-positive strains were not closely related to 
SHV-12, we obtained different results. The co-production 
rates of SHV were very high in the qnrB4 strain. SHV was 
produced in 17 strains among the 29-qnrB4 positive strains. 
Additionally, 12 SHV were co-produced among 22 strains 
that were positive for both DHA-1 and qnrB4, and 20 of 23 
DHA-1-positive strains harbored either SHV or CTX-M 
ESBLs. SHV-12 and DHA-1 were the most commonly ob-
served strains in this study. In a previous report, CTX-M 
was found to be rare among qnr-positive strains, and these 
strains were primarily qnrA-positive ones [13]. However, 14 
of 47 qnr-positive strains were CTX-M positive in the pres-
ent study. These strains and 10 CTX-M strains, including 3 
CTX-M-3, 1 CTX-M-9, and 1 CTX-M-15, harbored qnrB4. 
This was a characteristic finding in our series. Investigating 
the genetic environments, including CR1, to understand the 
mechanisms of association between qnr and ESBL is impor-
tant. Additional evaluation is required to obtain a precise un-
derstanding of these mechanisms.
In the present study, we verified that the qnr genes were 
prevalent among quinolone-susceptible strains as well as 
among quinolone-resistant strains. This suggests that the 
qnr gene is widely dispersed among Enterobacteriaceae. This 
is because of the high prevalence of qnrB4 strains, which are 
closely related to various ESBL and plasmid-mediated AmpC 
beta-lactamases.
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